Genentech, Immunocore, Biogen, Eli Lilly, TenSixteen
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Genentech
Immunocore
Biogen
Eli Lilly
TenSixteen
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Responses